Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign

Eur J Surg Oncol. 2016 Feb;42(2):288-96. doi: 10.1016/j.ejso.2015.09.022. Epub 2015 Oct 22.

Abstract

Background: During an ongoing phase II observational study on watch and wait policy in rectal cancer, a substantial number of patients presented residual lesion after radiotherapy with a clinical benign appearance. This article aims to discuss the clinical significance of such findings.

Materials and methods: Main entry criteria were age ≥70 years and small tumour (≤5 cm and ≤60% of circumferential involvement) located in the low rectum. Patients received chemoradiation (50 Gy, 2 Gy per fraction concomitantly with a 5-Fu bolus and leucovorin) or 5 × 5 Gy if considered unfit for chemotherapy. Patients with clinical complete response (cCR) were observed. Those with persistent tumours underwent transanal endoscopic microsurgery [TEM] if the baseline tumour was ≤3 cm and cN0 or total mesorectal excision.

Results: The watch and wait procedure was used in 11 out of the total 35 patients (31%) with a cCR; 17 patients (49%) with residual tumours that appeared clinically malignant were referred for TEM or abdominal surgery. In the remaining seven (20%), the residual tumour clinically appeared benign. Of these, there were two invasive cancers, four high-grade dysplasias and one low-grade dysplasia. The five patients with dysplasia, underwent local lesion resection without recurrence within a median of 11 months follow-up.

Conclusions: The majority of lesions that appeared clinically benign after radio(chemo)therapy were also benign on pathological examination. Thus, local excision of such lesions should be considered.

Keywords: Organ preservation; Preoperative radiotherapy; Rectal cancer.

Publication types

  • Clinical Trial, Phase II
  • Observational Study

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / therapy*
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemoradiotherapy*
  • Dose Fractionation, Radiation
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Leucovorin / administration & dosage
  • Male
  • Neoplasm, Residual
  • Organ Sparing Treatments
  • Rectal Neoplasms / pathology*
  • Rectal Neoplasms / therapy*
  • Transanal Endoscopic Microsurgery
  • Tumor Burden
  • Watchful Waiting*

Substances

  • Leucovorin
  • Fluorouracil